StonvexLoading…
StonvexStonvexStonvexCore line items from DBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $2.89B | $2.18B | $1.43B | $686.91M |
Operating Income | $47.76M | $61.98M | $19.32M | $-7.26M |
Net Income | $-8.37M | $11.62M | $-6.60M | $-17.42M |
EPS (Diluted) | $-0.17 | $0.23 | $-0.14 | $-0.36 |
Total Assets | $1.95B | $2.05B | $2.06B | $2.09B |
Total Liabilities | $1.66B | $1.75B | $1.78B | $1.82B |
Cash & Equivalents | $50.87M | $51.35M | $44.94M | $46.02M |
Free Cash Flow OCF − CapEx | $78.25M | $41.82M | $-15.68M | $-27.59M |
Shares Outstanding | 49.14M | 50.00M | 48.68M | 48.24M |